34 results on '"Coyer, Liza"'
Search Results
2. The Best Predictor of Future Behavior May Be the Past: Exploring Behavior Change in Men Who Have Sex with Men Using Pre-exposure Prophylaxis in the Netherlands
- Author
-
van Wees, Daphne, Coyer, Liza, van den Elshout, Mark, de Coul, Eline Op, and van Aar, Fleur
- Published
- 2024
- Full Text
- View/download PDF
3. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort
- Author
-
van den Elshout, Mark A. M., Wijstma, Eline S., Boyd, Anders, Jongen, Vita W., Coyer, Liza, Anderson, Peter L., Davidovich, Udi, de Vries, Henry J. C., Prins, Maria, Schim van der Loeff, Maarten F., and Hoornenborg, Elske
- Subjects
Medical research ,Medicine, Experimental ,Sexually transmitted diseases -- Statistics -- Physiological aspects -- Drug therapy ,MSM (Men who have sex with men) -- Sexual behavior -- Health aspects -- Drug therapy ,Biological sciences - Abstract
Background An increasing number of countries are currently implementing or scaling-up HIV pre-exposure prophylaxis (PrEP) care. With the introduction of PrEP, there was apprehension that condom use would decline and sexually transmitted infections (STIs) would increase. To inform sexual health counselling and STI screening programmes, we aimed to study sexual behaviour and STI incidence among men who have sex with men (MSM) and transgender women who use long-term daily or event-driven PrEP. Methods and findings The Amsterdam PrEP demonstration project (AMPrEP) was a prospective, closed cohort study, providing oral daily PrEP and event-driven PrEP to MSM and transgender women from 2015 to 2020. Participants could choose their PrEP regimen and could switch at each three-monthly visit. STI testing occurred at and, upon request, in-between 3-monthly study visits. We assessed changes in numbers of sex partners and condomless anal sex (CAS) acts with casual partners over time using negative binomial regression, adjusted for age. We assessed HIV incidence and changes in incidence rates (IRs) of any STI (i.e., chlamydia, gonorrhoea, or infectious syphilis) and individual STIs over time using Poisson regression, adjusted for age and testing frequency. A total of 367 participants (365 MSM) commenced PrEP and were followed for a median 3.9 years (interquartile range [IQR] = 3.4-4.0). Median age was 40 years (IQR = 32-48), 315 participants (85.8%) self-declared ethnicity as white and 280 (76.3%) had a university or university of applied sciences degree. Overall median number of sex partners (past 3 months) was 13 (IQR = 6-26) and decreased per additional year on PrEP (adjusted rate ratio [aRR] = 0.86/year, 95% confidence interval [CI] = 0.83-0.88). Overall median number of CAS acts with casual partners (past 3 months) was 10 (IQR = 3-20.5) and also decreased (aRR = 0.92/year, 95% CI = 0.88-0.97). We diagnosed any STI in 1,092 consultations during 1,258 person years, resulting in an IR of 87/100 person years (95% CI = 82-92). IRs of any STI did not increase over time for daily PrEP or event-driven PrEP users. Two daily PrEP users, and no event-driven PrEP users, were diagnosed with HIV during their first year on PrEP. Study limitations include censoring follow-up due to COVID-19 measures and an underrepresentation of younger, non-white, practically educated, and transgender individuals. Conclusions In this prospective cohort with a comparatively long follow-up period of 4 years, we observed very low HIV incidence and decreases in the numbers of casual sex partners and CAS acts over time. Although the STI incidence was high, it did not increase over time. Trial registration The study was registered at the Netherlands Trial Register (NL5413) https://www.onderzoekmetmensen.nl/en/trial/22706, Author(s): Mark A. M. van den Elshout 1,*, Eline S. Wijstma 1, Anders Boyd 1,2,3,4, Vita W. Jongen 1,2, Liza Coyer 1, Peter L. Anderson 5, Udi Davidovich 1,6, Henry [...]
- Published
- 2024
- Full Text
- View/download PDF
4. A psychosocial network approach studying biomedical HIV prevention uptake between 2017 and 2019
- Author
-
Zimmermann, Hanne M. L., Davidovich, Udi, van Bilsen, Ward P. H., Coyer, Liza, Matser, Amy, Prins, Maria, and van Harreveld, Frenk
- Published
- 2023
- Full Text
- View/download PDF
5. One Health in action: Investigation of the first detected local cluster of fatal borna disease virus 1 (BoDV-1) encephalitis, Germany 2022
- Author
-
Böhmer, Merle M., Haring, Viola C., Schmidt, Barbara, Saller, Franziska S., Coyer, Liza, Chitimia-Dobler, Lidia, Dobler, Gerhard, Tappe, Dennis, Bonakdar, Andrea, Ebinger, Arnt, Knoll, Gertrud, Eidenschink, Lisa, Rohrhofer, Anette, Niller, Hans Helmut, Katz, Katharina, Starcky, Philip, Beer, Martin, Ulrich, Rainer G., Rubbenstroth, Dennis, and Bauswein, Markus
- Published
- 2024
- Full Text
- View/download PDF
6. SARS-CoV-2 vaccination uptake in six ethnic groups living in Amsterdam, the Netherlands: A registry-based study within the HELIUS cohort
- Author
-
Campman, Sophie L., Boyd, Anders, Coyer, Liza, Schinkel, Janke, Agyemang, Charles, Galenkamp, Henrike, Koopman, Anitra D.M., Chilunga, Felix P., Schim van der Loeff, Maarten F., van Houtum, Lieke, Leenstra, Tjalling, Stronks, Karien, and Prins, Maria
- Published
- 2024
- Full Text
- View/download PDF
7. Bacterial sexually transmitted infections are concentrated in subpopulations of men who have sex with men using HIV pre-exposure prophylaxis
- Author
-
Jongen, Vita W., Van Der Loeff, Maarten F. Schim, Van Den Elshout, Mark, Wijstma, Eline, Coyer, Liza, Davidovich, Udi, De Vries, Henry J.C., Prins, Maria, Hoornenborg, Elske, and Boyd, Anders
- Published
- 2023
- Full Text
- View/download PDF
8. Changes in substance use among HIV-negative MSM: A longitudinal analysis, 1995-2019
- Author
-
Kelly, Brian C., Coyer, Liza, Mustillo, Sarah A., Prins, Maria, and Davidovich, Udi
- Published
- 2022
- Full Text
- View/download PDF
9. Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies
- Author
-
Jongen, Vita W., Reyniers, Thijs, Van Der Loeff, Maarten Schim, Smekens, Tom, Hoornenborg, Elske, Van Den Elshout, Mark, Zimmermann, Hanne, Coyer, Liza, Kenyon, Chris, De Baetselier, Irith, Davidovich, Udi, De Vries, Henry J.C., Prins, Maria, Laga, Marie, Vuylsteke, Bea, and Boyd, Anders
- Subjects
Antiviral agents -- Dosage and administration ,MSM (Men who have sex with men) -- Health aspects ,HIV infection -- Prevention ,Health - Abstract
: Introduction: Daily and event‐driven oral pre‐exposure prophylaxis (PrEP) reduce the risk of HIV acquisition. PrEP use can vary over time, yet little is known about the trajectories of PrEP use irrespective of the chosen PrEP regimens among men who have sex with men (MSM). Methods: Using data from a mobile, web‐based diary application collected daily from 17 August 2015 until 6 May 2018, we analysed PrEP use and sexual behaviour in two large cohorts, AMPrEP (Amsterdam, the Netherlands) and Be‐PrEP‐ared (Antwerp, Belgium). In both cohorts, participants could choose between daily and event‐driven oral PrEP every 3 months. We used group‐based trajectory modelling to identify trajectories of PrEP use over time and their determinants. In addition, we estimated the incidence rate of chlamydia, gonorrhoea and syphilis within these trajectories. Results: We included 516 MSM (n = 322 AMPrEP; n = 194 Be‐PrEP‐ared), of whom 24% chose event‐driven PrEP at PrEP initiation. Participants contributed 225,015 days of follow‐up (median = 508 days [IQR = 429−511]). Four distinct PrEP use trajectories were identified: ≤2 tablets per week (“low frequency,” 12% of the total population), 4 tablets per week (“variable,” 17%), “almost daily” (31%) and “always daily” (41%). Compared to participants with “low frequency” PrEP use, participants with “variable” (odds ratio [OR] = 2.18, 95% confidence interval [CI] = 1.04−4.60) and “almost daily” PrEP use were more often AMPrEP participants (OR = 2.64, 95% CI = 1.27−5.49). “Almost daily” PrEP users were more often employed (OR = 6.76, 95% CI = 2.10−21.75) and were younger compared to participants with “low frequency” PrEP use. In addition, the number of days on which anal sex occurred was lower among participants with “low frequency” PrEP use compared to the other groups (all p Conclusions: We uncovered four distinct PrEP use trajectories, pointing to different patterns of PrEP use in practice beyond the two‐regimen dichotomy. These trajectories were related to sexual behaviour and rates of sexually transmitted infection. Tailoring PrEP care according to different PrEP use patterns could be an important strategy to improve efficient PrEP delivery., INTRODUCTION Oral pre‐exposure prophylaxis (PrEP) is highly effective in reducing the risk of HIV acquisition when taken correctly [1–3]. Among cisgender men who have sex with men (MSM), PrEP can [...]
- Published
- 2023
- Full Text
- View/download PDF
10. Choosing event-driven and daily HIV pre-exposure prophylaxis--data from two European PrEP demonstration projects among men who have sex with men
- Author
-
Jongen, Vita W., Reyniers, Thijs, Ypma, Zorah M.H., Loeff, Maarten F. Schim van der, Davidovich, Udi, Zimmermann, Hanne M.L., Coyer, Liza, Elshout, Mark A.M. van den, deVries, Henry J.C., Wouters, Kristien, Smekens, Tom, Vuylsteke, Bea, Prins, Maria, Laga, Marie, and Hoornenborg, Elske
- Subjects
Patient compliance -- Methods ,MSM (Men who have sex with men) -- Drug therapy -- Behavior ,HIV infection -- Prevention -- Risk factors ,Health - Abstract
Introduction: Daily and event-driven PrEP are both efficacious in reducing the risk for HIV infection. However, the practice of event-driven PrEP (edPrEP) is less well studied, in particular when provided as an alternative to daily PrEP. We studied regimen preferences and switches, and sexually transmitted infection (STI) incidence. Methods: We analysed pooled data from two prospective cohort studies among MSM: Be-PrEP-ared, Belgium and AMPrEP, the Netherlands. In both projects, participants could choose between daily and edPrEP at three-monthly study visits, when they were also screened for sexually transmitted infections including hepatitis C (HCV). We assessed the proportion choosing each regimen, and the determinants of choosing edPrEP at baseline. Additionally, we compared the incidence rates (IRs) of HCV, syphilis and chlamydia or gonorrhoea between regimens using Poisson regression. The study period was from 3 August 2015 until 24 September 2018. Results and discussion: We included 571 MSM, of whom 148 (25.9%) chose edPrEP at baseline. 31.7% of participants switched regimen at least once. After 28 months, 23.5% used edPrEP. Older participants (adjusted odds ratio (aOR) = 1.38 per 10 years, 95% confidence interval (CI) = 1.15 to 1.64) and those unemployed (aOR = 1.68, 95% CI = 1.03 to 1.75) were more likely to initially choose edPrEP. IR of HCV and syphilis did not differ between regimens, but the IR of chlamydia/gonorrhoea was higher among daily users (adjusted incidence rate ratio = 1.61, 95% CI = 1.35 to 1.94). Conclusions: A quarter of participants chose edPrEP at baseline and at 28 months this proportion was similar. Although the IR of HCV and syphilis were similar in the two regimens, the lower incidence of chlamydia and gonorrhoea among edPrEP users may suggest that less frequent STI testing of this group could be considered. Keywords: pre-exposure prophylaxis; sexually transmitted infections; event-driven PrEP; syphilis; men who have sex with men; HIV prevention & control, 1 | INTRODUCTION Oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine, is efficacious for human immunodeficiency virus (HIV) prevention, provided that it is taken correctly [1-3]. Among men [...]
- Published
- 2021
- Full Text
- View/download PDF
11. Adherence to event-driven HIV PrEP among men who have sex with men in Amsterdam, the Netherlands: analysis based on online diary data, 3-monthly questionnaires and intracellular TFV-DP
- Author
-
Jongen, Vita W., Hoornenborg, Elske, van denElshout, Mark A.M., Boyd, Anders, Zimmermann, Hanne M.L., Coyer, Liza, Davidovich, Udi, Anderson, Peter L., deVries, Henry J.C., Prins, M., and van der Loeff, Maarten F. Schim
- Subjects
Patient compliance -- Evaluation ,MSM (Men who have sex with men) -- Health aspects ,HIV infection -- Prevention ,Health - Abstract
Introduction: Event-driven pre-exposure prophylaxis (edPrEP) with oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is highly effective for preventing HIV acquisition in men who have sex with men (MSM) and is preferred over daily PrEP by some MSM. However, it is largely unknown how well MSM adhere to edPrEP. We then aimed to assess PrEP protection during CAS among MSM using edPrEP and participating in the Amsterdam PrEP demonstration project (AMPrEP). Methods: We analysed data from participants enrolled in AMPrEP who were taking edPrEP. We measured adherence through (1) a mobile application in which sexual behaviour and PrEP-use were recorded daily, (2) three-monthly self-completed questionnaires and (3) dried blood spot (DBS) samples collected around six, twelve and twenty-four months after PrEP initiation. We assessed the proportion of days with condomless anal sex (CAS) acts that were protected by PrEP, per partner type (i.e. steady partners, known casual partners, unknown casual partners), and the proportion of three-month periods during which PrEP was correctly used. Intracellular TFV-diphosphate (TFV-DP) concentrations were determined from DBS. Good adherence was defined as at least one tablet before and one tablet within 48 hours after a CAS act. Results: Between 11 September 2015 and 6 October 2019, 182 of 376 MSM (48.4%) used edPrEP for at least one three-month period. Of the 8224 CAS days that were reported in the app during edPrEP-use, we observed good protection for most CAS days involving steady partners (n = 1625/2455, 66.9%), known casual partners (n = 3216/3472, 92.6%) and unknown casual partners (n = 2074/2297, 90.3%). Men reported consistently correct PrEP-use in 851 (81.4%) of the 1046 three-month periods of edPrEP-use. The median TFV-DP concentration was 591 fmol/sample (interquartile range = 270 to 896). Conclusions: Adherence to edPrEP was high as determined from the online app and questionnaire. DBS measurements were consistent with two to three tablets per week on average. Keywords: HIV; Pre-exposure prophylaxis; On-demand PrEP; medication adherence; HIV prevention and control; men who have sex with men, 1 | INTRODUCTION Pre-exposure prophylaxis (PrEP) has been proven to be highly effective against the acquisition of human immunodeficiency virus (HIV) [1,2]. The World Health Organization has therefore recommended that [...]
- Published
- 2021
- Full Text
- View/download PDF
12. Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men
- Author
-
Coyer, Liza, van den Elshout, Mark A M, Achterbergh, Roel C A, Matser, Amy, Schim van der Loeff, Maarten F, Davidovich, Udi, de Vries, Henry J C, Prins, Maria, Hoornenborg, Elske, and Boyd, Anders
- Published
- 2020
- Full Text
- View/download PDF
13. Hospitalisation rates differed by city district and ethnicity during the first wave of COVID-19 in Amsterdam, The Netherlands
- Author
-
Coyer, Liza, Wynberg, Elke, Buster, Marcel, Wijffels, Camiel, Prins, Maria, Schreijer, Anja, van Duijnhoven, Yvonne T. H. P., van Dam, Alje P., van der Lubben, Mariken, and Leenstra, Tjalling
- Published
- 2021
- Full Text
- View/download PDF
14. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study
- Author
-
Hoornenborg, Elske, Coyer, Liza, Achterbergh, Roel C A, Matser, Amy, Schim van der Loeff, Maarten F, Boyd, Anders, van Duijnhoven, Yvonne T H P, Bruisten, Sylvia, Oostvogel, Paul, Davidovich, Udi, Hogewoning, Arjan, Prins, Maria, and de Vries, Henry J C
- Published
- 2019
- Full Text
- View/download PDF
15. Sexual Behavior and Its Determinants During COVID-19 Restrictions Among Men Who Have Sex With Men in Amsterdam
- Author
-
van Bilsen, Ward P. H., Zimmermann, Hanne M. L., Boyd, Anders, Coyer, Liza, van der Hoek, Lia, Kootstra, Neeltje A., Hoornenborg, Elske, Prins, Maria, Schim van der Loeff, Maarten F., Davidovich, Udi, and Matser, Amy
- Published
- 2021
- Full Text
- View/download PDF
16. Evaluation of mpox contact tracing activities and data collection in EU/EEA countries during the 2022 multicountry outbreak in nonendemic countries.
- Author
-
Prins, Henrieke, Coyer, Liza, De Angelis, Stefania, Bluemel, Benjamin, Cauchi, Daniel, and Baka, Agoritsa
- Subjects
MONKEYPOX ,CONTACT tracing ,ACQUISITION of data ,INFECTIOUS disease transmission ,LIKERT scale ,IMPOTENCE ,SEXUAL health - Abstract
To control human‐to‐human mpox transmission during the 2022 outbreak, European Union (EU)/European Economic Area (EEA) countries conducted case investigation and contact tracing (CT). We aimed to provide an overview of CT activities, describe CT data collection practices, and identify related facilitators, barriers, and potential opportunities for improvement. Between April 03, 2023 and May 12, 2023, a survey was distributed to CT stakeholders in 30 EU/EEA countries, asking about mpox CT activities and data collection and requesting to rank enablers, barriers, and improvements for CT on a five‐point Likert scale. The 139 respondents from 27 countries indicated having performed case investigations (96%, n = 133), backward CT (88%, n = 122), forward CT (87%, n = 121), and follow‐up on contacts' outcomes (77%, n = 107). Sixty percent (n = 80/134) used standardized data collection forms and 73% (n = 91/124) used databases. The highest‐rated enablers were clear guidelines (mean = 3.9), quick access to laboratory results (3.6), and sufficient expertise (3.6). Highly rated barriers were inability to contact contacts (3.0) or cases (2.5) and lack of staff (2.4). The most needed improvements were availability of staff (3.5), expertise on affected populations (3.4) and data reporting tools and systems (3.3). To improve CT of mpox and diseases with similar transmission patterns, EU/EEA countries should increase workforce capacity in public and sexual health, offer training on CT operations and communication with affected communities, and use common CT data collection tools and systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Determinants of adherence to daily PrEP measured as intracellular tenofovir diphosphate concentrations over 24 months of follow-up among men who have sex with men.
- Author
-
van den Elshout, Mark A. M., Hoornenborg, Elske, Coyer, Liza, Anderson, Peter L., Davidovich, Udi, de Vries, Henry J. C., Prins, Maria, and van der Loeff, Maarten F. Schim
- Published
- 2023
- Full Text
- View/download PDF
18. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.
- Author
-
Jongen, Vita W., Zimmermann, Hanne M. L., Goedhart, Marit, Bogaards, Johannes A., Davidovich, Udi, Coyer, Liza, de Vries, Henry J. C., Prins, Maria, Hoornenborg, Elske, and van der Loeff, Maarten F. Schim
- Published
- 2023
- Full Text
- View/download PDF
19. Knowledge, Attitudes and Behaviors regarding Tick-Borne Encephalitis Vaccination and Prevention of Tick-Borne Diseases among Primary Care Physicians in Bavaria and Baden-Wuerttemberg, Germany, May–September 2022.
- Author
-
Coyer, Liza, Sogan-Ekinci, Aylin, Greutélaers, Benedikt, Kuhn, Julia, Saller, Franziska S., Hailer, Jana, Böhm, Stefanie, Brosch, Rainer, Wagner-Wiening, Christiane, and Böhmer, Merle M.
- Subjects
TICK-borne encephalitis ,TICK-borne diseases ,POSTVACCINAL encephalitis ,PRIMARY care ,PREVENTIVE medicine - Abstract
In 2020, a record number of tick-borne encephalitis (TBE) cases was reported in major endemic areas in Germany, i.e., the southern federal states of Baden-Wuerttemberg and Bavaria. Most cases were unvaccinated. Other tick-borne diseases (TBDs), including Lyme borreliosis and tularemia, are rising, too. Thus, strategies are needed to increase TBE vaccination uptake in risk areas and promote education on TBD prevention. Primary care physicians are key providers of both vaccinations and TBD education. The TBD-Prevention (TBD-Prev) study aimed to investigate the knowledge, attitudes and behaviors of primary care physicians in Baden-Wuerttemberg and Bavaria with regard to TBE vaccination and prevention of TBDs and to derive strategies for increasing vaccination rates and improving knowledge about TBE and other TBDs in the population and among primary care physicians. We invited all primary care physicians (N = 14,046) in both states to participate by mail. Using standardized, self-administered questionnaires, available both on paper and online, we asked physicians anonymously about their knowledge, attitudes and behaviors with respect to TBE vaccination and TBD prevention and their need for further information/educational materials. A total of 2321 physicians participated between May and September 2022 (response rate 17%), of whom 1222 (53%) worked in Baden-Wuerttemberg and 1067 (46%) in Bavaria. Among the participating physicians, 56% were male, 71% were >50 years and 51% worked in an individual practice. Furthermore, 91% were aware of the German national vaccination guidelines, and 98% perceived their knowledge of the risks and benefits of vaccination as adequate. A total of 97% offer TBE vaccinations, 67% provide vaccination counselling during initial consultations with new patients and 64% actively remind patients about due vaccinations. In addition, 24% expressed a need for further information materials, mainly traditional, analogue media such as flyers (82%) and posters (50%), and named timeliness, quality assurance, easy comprehensibility and independence from the pharmaceutical industry as the most important characteristics of such materials. Almost all participating physicians reported offering TBE vaccinations and feeling well-informed about TBE vaccination and TBDs. However, active offering of vaccinations and education could be further improved, and additional, low-threshold information materials are needed. Based on these results, we will develop and provide various materials on TBE vaccination and TBDs, in particular flyers and posters, for use by physicians during consultations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. The impact of COVID‐19‐related restrictions in 2020 on sexual healthcare use, pre‐exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
- Author
-
de la Court, Feline, Boyd, Anders, Coyer, Liza, van den Elshout, Mark, de Vries, Henry J. C., Matser, Amy, Hoornenborg, Elske, and Prins, Maria
- Subjects
EPIDEMIOLOGY of sexually transmitted diseases ,HIV infections ,CONFIDENCE intervals ,DISEASE incidence ,MEDICAL care use ,PRE-exposure prophylaxis ,COMPARATIVE studies ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,RESEARCH funding ,SOCIAL distancing ,STAY-at-home orders ,MEN who have sex with men ,LOGISTIC regression analysis ,COVID-19 pandemic ,SEXUAL health ,LONGITUDINAL method ,SECONDARY analysis ,POISSON distribution - Abstract
Objectives: We studied the effects of restrictions related to the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2; coronavirus disease 2019 [COVID‐19]) pandemic on the use of sexual healthcare and pre‐exposure prophylaxis (PrEP) and on the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM) in a prospective, open‐label PrEP demonstration study (AMPrEP) in Amsterdam, the Netherlands. Methods: We retrieved data from 2019 to 2020 for participants with one or more study visit in 2019 (n = 305) and from two COVID‐19 questionnaires (2020: n = 203; 2021: n = 160). Analyses were stratified for three periods of pandemic‐related restrictions (first: 15 March 2020–15 June 2020; second: 16 June 2020–15 September 2020; third: 16 September 2020–31 December 2020 or 1 April 2021 for the COVID‐19 questionnaire). Endpoints included returning for care during the pandemic, PrEP use (increased/unchanged vs. deceased/stopped, relative to 2019), and any STI/HIV. We modelled determinants of care and PrEP use via multivariable logistic regression and STI incidence using piecewise Poisson regression, comparing the 2020 and 2019 periods. Results: Of the 305 MSM included in the analysis, 72.8% returned for care during the pandemic, and this was significantly more likely among daily (vs. event‐driven) PrEP users (p < 0.001). Increased/unchanged PrEP use ranged from 55.2% to 58.1% across the three pandemic periods and was more likely among those reporting chemsex in the first (p = 0.001) and third (p = 0.020) periods and among those reporting an increased/unchanged number of sex partners during the second period (p = 0.010). STI incidence was significantly lower in 2020 than in 2019 during the first period (incidence rate ratio [IRR] 0.43; 95% confidence interval [CI] 0.28–0.68) and not significantly different during the second (IRR 1.38; 95% CI 0.95–2.00) and third (IRR 1.42; 95% CI 0.86–2.33) periods. No HIV was diagnosed. Conclusion: COVID‐19‐related restrictions coincided with reduced care and PrEP use. Changes in STI incidence suggest delayed diagnoses. Ways to ensure continued access to sexual healthcare during restrictions are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. SARS-CoV-2 Prevalence on and Incidence after Arrival in Travelers on Direct Flights from Cape Town, South Africa to Munich, Germany Shortly after Occurrence of the Omicron Variant in November/December 2021: Results from the OMTRAIR Study.
- Author
-
Seidl, Cornelia, Coyer, Liza, Ackermann, Nikolaus, Katz, Katharina, Walter, Jan, Ippisch, Siegfried, Hoch, Martin, and Böhmer, Merle M.
- Subjects
SARS-CoV-2 Omicron variant ,SARS-CoV-2 ,COVID-19 ,VACCINATION status ,DIAGNOSTIC use of polymerase chain reaction ,TRAVEL restrictions - Abstract
The highly transmissible SARS-CoV-2-variant B.1.1.529 (Omicron) first appeared in South Africa in November 2021. In order to study Omicron entry to Germany, its occurrence related to incoming airline travel, symptomatology and compliance with entry regulations and recommendations, we conducted a cross-sectional study, followed by a retrospective cohort study among passengers and crew on 19 direct flights from Cape Town, South Africa, to Munich, Germany, between 26 November and 23 December 2021. Travelers were mandatorily PCR-tested on arrival and invited to complete an online questionnaire. SARS-CoV-2-prevalence on arrival was 3.3% (n = 90/2728), and 93% were Omicron. Of the passengers, 528 (19%) completed the questionnaire. Among participants who tested negative on arrival, self-reported SARS-CoV-2-incidence was 4.3% within 14 days, of whom 74% reported a negative PCR-test ≤ 48 h before boarding, 77% were fully vaccinated, and 90% reported wearing an FFP2/medical mask during flight. We found multiple associations between risk factors and infection on and after arrival, among which having a positive-tested travel partner was the most noteworthy. In conclusion, PCR testing before departure was insufficient to control the introduction of the Omicron variant. Additional measures (e.g., frequent testing, quarantine after arrival or travel ban) should be considered to delay virus introduction in such settings. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
22. Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands:Observational Study.
- Author
-
Ritsema, Feiko, Bosdriesz, Jizzo R., Leenstra, Tjalling, Petrignani, Mariska W. F., Coyer, Liza, Schreijer, Anja J. M., van Duijnhoven, Yvonne T. H. P., van de Wijgert, Janneke H. H. M., Schim van der Loeff, Maarten F., and Matser, Amy
- Published
- 2022
- Full Text
- View/download PDF
23. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
- Author
-
Coyer, Liza, Prins, Maria, Davidovich, Udi, van Bilsen, Ward P.H., Schim van der Loeff, Maarten F., Hoornenborg, Elske, Matser, Amy, and Boyd, Anders
- Subjects
- *
HUMAN sexuality , *SEXUALLY transmitted diseases , *SEX customs , *MEN who have sex with men , *HIV , *LONGITUDINAL method - Abstract
Men who have sex with men (MSM) initiating human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) may increase condomless anal sex (CAS) and number of partners, and, consequently, more often acquire sexually transmitted infections (STIs). Using data from the Amsterdam Cohort Studies, we compared sexual behavior and STI among MSM after PrEP-initiation with controls not initiating PrEP. The MSM reported on sexual behavior and were tested for HIV, chlamydia, gonorrhea, and syphilis semi-annually. We matched MSM who initiated PrEP between January 1, 2015 and December 31, 2019 1:1 to MSM who did not use time-dependent propensity scores based on age, sexual behavior, and STI. Primary end-points were number of casual partners, and proportion with CAS and receptive CAS (rCAS) with casual partners, sexualized drug use (SDU), any STI, and anal STI. We modeled end-points during the 4 years before and 2 years after PrEP-initiation or matched PrEP-initiation timepoint by using logistic regression (dichotomous end-points) or negative binomial regression (count end-point), adjusted for calendar year. Two hundred twenty-eight out of the 858 (26.6%) MSM initiated PrEP. We matched 198 out of 228 (86.8%) to a control. Before PrEP-initiation, end-points increased over time in both groups, with no statistically significant difference. The odds of CAS, rCAS, and anal STI were on average higher after than before PrEP-initiation in PrEP initiators, whereas after versus before differences were not observed in controls. After PrEP-initiation, PrEP initiators had statistically significantly more casual partners, and higher odds of CAS, rCAS, SDU, any STI, and anal STI than controls. These findings support frequent STI screening and counseling in MSM using PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV-negative men who have sex with men.
- Author
-
Coyer, Liza, Boyd, Anders, Davidovich, Udi, van Bilsen, Ward P. H., Prins, Maria, and Matser, Amy
- Subjects
- *
RISK-taking behavior , *CONFIDENCE intervals , *SELF-evaluation , *DRUG abuse , *PUBLIC health , *SEXUALLY transmitted diseases , *DESCRIPTIVE statistics , *MEN who have sex with men , *LOGISTIC regression analysis , *ODDS ratio , *UNSAFE sex , *LONGITUDINAL method - Abstract
Aims: To test whether recreational drug use (RDU) and sexualized drug use (SDU) changed in the Amsterdam area between 2008 and 2018 and quantify associations of SDU with condomless anal sex (CAS), recent human immunodeficiency virus (HIV) or sexually transmitted infections (STI) among human immunodeficiency virus (HIV)-negative men who have sex with men (MSM). Design: Open prospective cohort study. Setting: Public Health Service of Amsterdam, the Netherlands. Participants: A total of 976 HIV-negative MSM, aged = 18 years. Measurements: Self-reported RDU and sexual behaviour in the past 6 months. Laboratory-confirmed HIV and STI (chlamydia, gonorrhoea and syphilis). We studied: any RDU; any SDU (i.e. any RDU during sex); specific SDU (i.e. use of mephedrone, methamphetamine, gamma-hydroxybutyric acid/gamma-butyrolactone, ketamine, amphetamine, cocaine and/or ecstasy during sex); use of individual drugs; and use of individual drugs during sex. We evaluated changes over calendar years in the proportion of individuals with these end-points [using logistic regression with generalized estimating equations (GEE)] and number of drugs (using negative binomial regression with GEE), adjusted for current age, country of birth and education level. Findings: Median age of participants in 2008 was 33.2 years (interquartile range = 27.8-40.1); 83.1% were born in the Netherlands. The proportion of any RDU increased from 67.2% in 2008 to 69.5% in 2018 [adjusted odds ratio (aOR) = 1.25; 95% confidence interval (CI) = 1.03-1.51]. Any SDU increased from 53.8% in 2008 to 59.8% in 2013 (aOR = 1.23; 95% CI = 1.07-1.42) and remained stable afterwards. Specific SDU increased from 25.0% in 2008 to 36.1% in 2018 (aOR = 2.10; 95% CI = 1.71-2.58). The average number of drugs used increased for those reporting any RDU, any SDU and specific SDU (all P < 0.05. Among those engaging in sex, any SDU was associated with CAS (aOR = 1.36; 95% CI = 1.19-1.55), HIV (aOR = 5.86; 95% CI = 2.39-14.4) and STI (aOR = 2.31; 95% CI = 1.95-2.73). Specific SDU was associated with CAS (aOR = 1.58; 95% CI = 1.37-1.81), HIV (aOR = 6.30; 95% CI = 3.28-12.1) and STI (aOR = 2.15; 95% CI = 1.81-2.55). Conclusions: Among human immunodeficiency virus (HIV)-negative men who have sex with men in Amsterdam, recreational drug use, including sexualized drug use, increased between 2008 and 2018. Sexualized drug use was strongly associated with condomless anal sex, HIV and sexually transmitted infections. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Self-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands.
- Author
-
Bosdriesz, Jizzo R., Ritsema, Feiko, Leenstra, Tjalling, Petrignani, Mariska W. F., Bruisten, Sylvia M., Coyer, Liza, Schreijer, Anja J. M., van Duijnhoven, Yvonne T. H. P., Schim van der Loeff, Maarten F., and Matser, Amy A.
- Subjects
COUGH ,SMELL ,GENERALIZED estimating equations ,RHINORRHEA ,SYMPTOMS ,SARS-CoV-2 ,INFECTION - Abstract
Introduction: Most COVID-19 symptoms are non-specific and also common in other respiratory infections. We aimed to assess which symptoms are most predictive of a positive test for SARS-CoV-2 in symptomatic people of the general population who were tested. Methods: We used anonymised data of all SARS-CoV-2 test results from the Public Health Service of Amsterdam from June 1,2020 through August 31, 2021. Symptoms were self-reported at time of requesting a test. Multivariable logistic regression models with generalized estimating equations were used to identify predictors of a positive test. Included symptoms were: cough, fever, loss of smell or taste, muscle ache, runny nose, shortness of breath, and throat ache; adjustments were made for age and gender, and stratification by month. Results: Overall, 12.0% of 773,680 tests in 432,213 unique individuals were positive. All symptoms were significantly associated with a positive test result, the strongest positive associations were: cough (aOR = 1.78, 95%CI = 1.75–1.80), fever (aOR = 2.11, 95%CI = 2.07–2.14), loss of smell or taste (aOR = 2.55, 95%CI = 2.50–2.61), and muscle ache (aOR = 2.38, 95%CI = 2.34–2.43). The adjusted odds ratios for loss of smell or taste slightly declined over time, while that for cough increased. Conclusion: Cough, fever, loss of smell or taste, and muscle ache appear to be most strongly associated with a positive SARS-CoV-2 test in symptomatic people of the general population who were tested. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
26. Improving adherence to daily preexposure prophylaxis among MSM in Amsterdam by providing feedback via a mobile application.
- Author
-
van den Elshout, Mark A. M., Hoornenborg, Elske, Achterbergh, Roel C. A., Coyer, Liza, Anderson, Peter L., Davidovich, Udi, de Vries, Henry J. C., Prins, Maria, and van der Loeff, Maarten F. Schim
- Published
- 2021
- Full Text
- View/download PDF
27. Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.
- Author
-
Jongen, Vita W., Zimmermann, Hanne M. L., Boyd, Anders, Hoornenborg, Elske, van den Elshout, Mark A. M., Davidovich, Udi, van Duijnhoven, Yvonne T. H. P., de Vries, Henry J. C., Prins, Maria, van der Loeff, Maarten F. Schim, and Coyer, Liza
- Published
- 2021
- Full Text
- View/download PDF
28. Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project.
- Author
-
Coyer, Liza, Njoya, Oudou, Njouom, Richard, Mossus, Tatiana, Kowo, Mathurin Pierre, Essomba, Frida, Boers, Alexander, Coutinho, Roel, Ondoa, Pascale, Bilong, Catherine, Babagnak, Isabelle Dang, Kamto, Dyane, Talla, Paul, Tchoumi, Eric, and HEP C-IMPACT Team
- Subjects
- *
CHRONIC hepatitis C , *HEPATITIS C virus , *VIRUS diseases , *PILOT projects - Abstract
Objectives: Highly effective direct-acting antivirals (DAAs) for Hepatitis C treatment are largely inaccessible in sub-Saharan Africa. Data on treatment feasibility and outcomes in clinical settings are limited. We assessed the feasibility of achieving a high (≥90%) cure rate with DAAs in six gastroenterology clinics in Cameroon.Methods: Patients with chronic Hepatitis C virus (HCV) infection were treated for 12 or 24 weeks with ledipasvir/sofosbuvir, ledipasvir/sofosbuvir/ribavirin or sofosbuvir/ribavirin, depending on the stage of liver disease and HCV genotype. The cure rate was defined as the proportion of patients with a sustained virological response 12 weeks after treatment completion (SVR12) among all treatment completers.Results: We identified 190 HCV RNA positive patients between September-2017 and August-2018, 161 (84.7%) of whom started treatment. 105 (65.2%) were female, median age was 61.3 years [IQR = 55.9-66.9] and 11 (6.8%) were HIV-positive. Median plasma HCV RNA was 6.0 log10 IU/mL [IQR = 5.6-6.4]. HCV genotypes identified were 1 (34.8%), 2 (13.7%), 4 (50.9%), 1 and 4 (0.6%); 46 (28.6%) strains of 160 single-genotype infections were non-subtypeable. Of 158 treatment completers, 152 (96.2%, 95%CI = 91.9-98.6%) achieved SVR12. Six patients did not achieve SVR12: five carried HCV with NS5A resistance mutations and one with NS5B resistance mutations. Three patients died before and two after treatment completion. The most common adverse events were asthenia (12.0%), headache (11.4%) and dizziness (18.9%).Conclusion: High cure rates of Hepatitis C with DAAs are achievable in clinical settings of Cameroon. However, the accessibility and provision of HCV screening, diagnosis, treatment, monitoring and care should be addressed for large-scale implementation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
29. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
- Author
-
Hoornenborg, Elske, Coyer, Liza, Boyd, Anders, Achterbergh, Roel Christiaan Alfons, Schim van der Loeff, Maarten Franciscus, Bruisten, Sylvia, de Vries, Henry John Christiaan, Koopsen, Jelle, van de Laar, Thijs J.W., and Prins, Maria
- Subjects
- *
PRE-exposure prophylaxis , *SEXUALLY transmitted diseases , *GONORRHEA , *BLOODBORNE infections , *HIV infections , *HIV-positive men , *INFECTION - Abstract
HCV has emerged as a sexually transmitted infection (STI) among HIV-positive men who have sex with men (MSM). We evaluated HCV incidence and its risk factors among HIV-negative MSM using HIV pre-exposure prophylaxis (PrEP). Participants of the Amsterdam PrEP project were tested for HCV antibodies or HCV-RNA every 6 months. Participants used daily or event-driven PrEP and could switch regimens during follow-up. We calculated incidence rates (IRs) for overall HCV infection and separately for primary and re-infection. A univariable Bayesian exponential survival model was used to identify risk factors associated with incident HCV infection. The HCV NS5B gene fragment (709 bp) was sequenced and compared to HCV isolates from HIV-positive MSM and other risk groups (n = 419) using phylogenetic analysis. Among 350 participants contributing 653.6 person-years (PYs), we detected 15 HCV infections in 14 participants (IR = 2.30/100PY). There were 8 primary infections (IR = 1.27/100PY) and 7 re-infections (IR = 27.8/100PY). IR was 2.71/100PY in daily and 1.15/100PY in event-driven PrEP users. Factors associated with incident HCV infection were higher number of receptive condomless anal sex acts with casual partners (posterior hazard ratio [HR] 1.57 per ln increase; 95% credibility interval [CrI] 1.09–2.20), anal STI (posterior HR 2.93; 95% CrI 1.24–7.13), injecting drug use (posterior HR 4.69; 95% CrI 1.61–12.09) and sharing straws when snorting drugs (posterior HR 2.62; 95% CrI 1.09–6.02). We identified robust MSM-specific HCV clusters of subtypes 1a, 4d, 2b and 3a, which included MSM with and without HIV. HIV-negative MSM using PrEP are at risk of incident HCV infection, while identified risk factors are similar to those in HIV-positive MSM. Regular HCV testing is needed, especially for those with a previous HCV infection and those reporting risk factors. We report that hepatitis C virus infections are frequently acquired among HIV-negative men who have sex with men (MSM) using pre-exposure prophylaxis to prevent HIV infection. New infections occurred more frequently in those reporting receptive anal sex without using condoms, having an anal sexually transmitted infection, injecting drugs, and sharing straws when snorting drugs. The viruses found in HIV-negative men using pre-exposure prophylaxis are genetically similar to those in HIV-positive men, but not in other hepatitis C risk groups, suggesting that (sexual) transmission is occurring between HIV-positive MSM and HIV-negative MSM using pre-exposure prophylaxis. Dutch trial registration number NTR5411. • HIV-negative men who have sex with men while on pre-exposure prophylaxis are at risk of incident HCV infection. • High incidence rates of both HCV primary and re-infection were observed. • Identified HCV risk-factors were similar to those in HIV-positive men who have sex with men. • Specific clusters of HCV strains were identified in men who have sex with men, with and without HIV. • HCV-testing for HIV-negative men who have sex with men while on pre-exposure prophylaxis is recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. SEXUAL BEHAVIOR AND STI INCIDENCE DURING THE FIRST 4 YEARS OF PrEP USE AMONG MSM.
- Author
-
den Elshout, Mark van, Wijstma, Eline, Jongen, Vita, Coyer, Liza, Boyd, Anders, Davidovich, Udi, de Vries, Henry, Prins, Maria, Van Der Loeff, Maarten Schim, and Hoornenborg, Elske
- Published
- 2023
31. Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.
- Author
-
Coyer, Liza, van Bilsen, Ward, Bil, Janneke, Davidovich, Udi, Hoornenborg, Elske, Prins, Maria, and Matser, Amy
- Subjects
- *
HIV infections , *PREVENTIVE medicine , *HEALTH insurance , *MEN who have sex with men , *LOGISTIC regression analysis , *HEALTH - Abstract
Objective: Currently, HIV pre-exposure prophylaxis (PrEP) is not covered by health insurance in the Netherlands. We examined time trends in use of PrEP, characteristics of PrEP users, PrEP eligibility and intention to use PrEP among HIV-negative men who have sex with men (MSM) participating in the Amsterdam Cohort Studies (ACS). Design: Prospective cohort study. Methods: We used data from four 6-monthly questionnaire waves, collected between 2015–2017. PrEP use over time was examined in logistic regression models using generalized estimating equations. Using descriptive statistics, we compared PrEP users before first-time initiation to non-PrEP-users. We used national guidelines to assess PrEP eligibility. Results: We included 687 MSM. Median age was 40 (IQR 33–47) years in 2015. Recent PrEP use was reported by 57/687 (8%) MSM. PrEP use increased over calendar time (P<0.001) to 7% in 2017. PrEP users did not differ from non-PrEP users in socio-demographic characteristics, but reported a significantly higher median number of casual sex partners, more often reported condomless anal sex and chemsex with casual partners, and more often had an sexually transmitted infection in the preceding 6 months (all P<0.05). PrEP eligibility increased over time, but the effect was not statistically significant (P = 0.075). PrEP eligibility criteria were met by 149/460 (32%) at wave 4, of whom 31/149 (21%) reported use of PrEP. The proportion with a high intention to use PrEP was greater among eligible than non-eligible MSM (51% vs. 24%, P<0.001). Conclusion: PrEP use increased over time but remained under 10%, even though 32% met the eligibility criteria, of whom 51% had a high intention to use PrEP. This suggests that a large proportion of Dutch MSM at risk could benefit from PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. Change in sexual risk behaviour after 6 months of pre-exposure prophylaxis use: results from the Amsterdam pre-exposure prophylaxis demonstration project.
- Author
-
Hoornenborg, Elske, Coyer, Liza, van Laarhoven, Anna, Achterbergh, Roel, de Vries, Henry, Prins, Maria, van der Loeff, Maarten Schim, and Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam Initiative
- Published
- 2018
- Full Text
- View/download PDF
33. A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands - the HELIUS study.
- Author
-
Kovaleva, Alexandra, Alberts, Catharina J., Waterboer, Tim, Michel, Angelika, Snijder, Marieke B., Vermeulen, Wilma, Coyer, Liza, Prins, Maria, and van der Loeff, Maarten Schim
- Subjects
HUMAN papillomavirus vaccines ,PAPILLOMAVIRUS pathogenicity ,SEXUALLY transmitted disease treatment ,BLOOD sampling ,SEXUAL health - Abstract
Background: Acquisition of genital human papillomavirus (HPV) infection is common among the young, sexually active population. Genital HPV infections do not always lead to seroconversion. We aimed to assess the association between cervico-vaginal high risk (hr) HPV DNA and type-specific antibodies in an ethnically diverse cohort of young women. Methods: Women of Dutch, South-Asian Surinamese, African Surinamese, Ghanaian, Moroccan and Turkish origin participating in a large-scale multi-ethnic population-based cohort (the HELIUS study) provided vaginal self-samples and blood samples, and completed a questionnaire regarding demographics, lifestyle and sexual health. Vaginal swabs were tested for HPV using the highly sensitive SPF10-PCR DEIA/LiPA25 system (version1). Serum samples were tested for typespecific L1 antibodies against 7 hrHPV types (16,18,31,33,45,52,58) with multiplex serology. We assessed the association between vaginal HPV DNA and type-specific seropositivity with logistic and linear regression, using generalized estimating equations (GEE). We determined whether this association varies by ethnicity by adding an interaction term. Results: We selected 532 women who completed the questionnaire, provided a vaginal swab and a blood sample. Their median age was 27 years (interquartile range 24-31 years). Prevalence of DNA of any of the 7 hrHPV was 22 %; HPV-52 was most common. Prevalence of antibodies against one or more hrHPV types was 24 %; HPV-16 seropositivity was most common. In multivariable logistic regression analysis using GEE, adjusting for other determinants, vaginal HPV DNA detection was associated with type-specific HPV seropositivity (OR 1.53, 95 % CI 1.06-2.20). In multivariable linear regression analysis using GEE, the geometric mean of type-specific antibody reactivity was 1.15 (95 % CI 1.04-1.27) times higher in women positive for HPV DNA compared to HPV DNA-negative women. There was little evidence that ethnicity modified the association between HPV DNA, and type-specific seropositivity, or with antibody reactivities (p =0.47 and p = 0.57, respectively).Conclusions: In this multi-ethnic group of young women in Amsterdam, cervico-vaginal hrHPV DNA detection was an independent determinant of type-specific HPV seropositivity. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
34. Intent to vaccinate against SARS-CoV-2 and its determinants across six ethnic groups living in Amsterdam, the Netherlands: A cross-sectional analysis of the HELIUS study.
- Author
-
Campman, Sophie L., van Rossem, Gwen, Boyd, Anders, Coyer, Liza, Schinkel, Janke, Agyemang, Charles, Galenkamp, Henrike, Koopman, Anitra D.M., Leenstra, Tjalling, Schim van der Loeff, Maarten, Moll van Charante, Eric P., van den Born, Bert-Jan H., Lok, Anja, Verhoeff, Arnoud, Zwinderman, Aeilko H., Jurriaans, Suzanne, Stronks, Karien, and Prins, Maria
- Subjects
- *
ETHNIC groups , *SARS-CoV-2 , *VACCINATION , *CROSS-sectional method , *HEALTH equity , *IMMUNOGLOBULINS - Abstract
• SARS-CoV-2 vaccination intent was remarkably lower in ethnic minority groups. • Females and those believing COVID-19 was exaggerated in the media commonly had lower intent. • Other determinants of lower intent were specific to certain ethnic groups. • Low intent could exacerbate existing inequalities of COVID-19 between ethnic groups. • Targeted strategies are warranted to address the needs of specific ethnic groups. Ethnic minority groups experience a disproportionately high burden of infections, hospitalizations and mortality due to COVID-19, and therefore should be especially encouraged to receive SARS-CoV-2 vaccination. This study aimed to investigate the intent to vaccinate against SARS-CoV-2, along with its determinants, in six ethnic groups residing in Amsterdam, the Netherlands. We analyzed data of participants enrolled in the population-based multi-ethnic HELIUS cohort, aged 24 to 79 years, who were tested for SARS-CoV-2 antibodies and answered questions on vaccination intent from November 23, 2020 to March 31, 2021. During the study period, SARS-CoV-2 vaccination in the Netherlands became available to individuals working in healthcare or > 75 years old. Vaccination intent was measured by two statements on a 7-point Likert scale and categorized into low, medium, and high. Using ordinal logistic regression, we examined the association between ethnicity and lower vaccination intent. We also assessed determinants of lower vaccination intent per ethnic group. A total of 2,068 participants were included (median age 56 years, interquartile range 46–63). High intent to vaccinate was most common in the Dutch ethnic origin group (369/466, 79.2%), followed by the Ghanaian (111/213, 52.1%), South-Asian Surinamese (186/391, 47.6%), Turkish (153/325, 47.1%), African Surinamese (156/362, 43.1%), and Moroccan ethnic groups (92/311, 29.6%). Lower intent to vaccinate was more common in all groups other than the Dutch group (P < 0.001). Being female, believing that COVID-19 is exaggerated in the media, and being < 45 years of age were common determinants of lower SARS-CoV-2 vaccination intent across most ethnic groups. Other identified determinants were specific to certain ethnic groups. Lower intent to vaccinate against SARS-CoV-2 in the largest ethnic minority groups of Amsterdam is a major public health concern. The ethnic-specific and general determinants of lower vaccination intent observed in this study could help shape vaccination interventions and campaigns. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.